Heterozygous loss of Bmp4 results both in humans and mice in severe malformation of the urinary tract. These defects have at least partially been attributed to loss of expression of Bmp4 in the ureteric mesenchyme, yet the cellular and molecular function of this signal as well as its effector pathways in this tissue have remained incompletely resolved. Here, we show that mice with a conditional deletion of Bmp4 in the ureteric mesenchyme exhibited hydroureter and hydronephrosis at newborn stages due to functional and physical ureter obstruction. Proliferation in both the mesenchymal and epithelial progenitor pools was severely reduced and smooth muscle cell and urothelial differentiation programs were not activated. Epithelial expression of P-ERK1/2, P-AKT and P-P38, and mesenchymal expression of P-SMAD1/5/9, P-P38 and P-AKT were abrogated. Pharmacological inhibition and activation experiments in ureter cultures defined AKT as the most relevant downstream effector for epithelial and mesenchymal proliferation as well as for epithelial differentiation. Epithelial proliferation and differentiation were also influenced by P-38 and ERK1/2, while SMAD signaling, together with AKT and P-38, were required for smooth muscle cell differentiation. Our analysis suggests that BMP4 is the signal that couples the proliferation and differentiation programs in the epithelial and mesenchymal tissue compartments of the developing ureter by different downstream effectors, most importantly AKT and SMAD.
Introduction
Congenital anomalies of the kidney and urinary tract (CAKUT) comprise a wide range of structural malformations that result from defects in development (1) . To date, almost 40 monogenic recessive or dominant causes of human CAKUT have been identified (2) . One of these genes is BMP4, encoding a member of the family of secreted bone morphogenetic proteins, in which three missense mutations have been identified in five patients with renal agenesis, renal hypoplasia and renal cystic dysplasia (3) . About 50% of mice heterozygous for a null allele of Bmp4 exhibit CAKUT at birth; of these two thirds had hypo-or dysplastic kidneys, and one third hydroureter with associated hydronephrosis, while about a tenth had duplex kidneys with bifid ureters, confirming haploinsufficiency of the locus and pointing to a wider role of the gene in the development of the upper urinary tract (4, 5) .
In the mouse, the kidneys and ureters arise from embryonic day (E)10.5 onwards from a common primordium in the intermediate mesoderm, the epithelial ureteric bud, and its surrounding mesenchyme. The proximal aspect of the ureteric bud repeatedly branches and differentiates into the mature collecting duct system of the kidney. The mesenchyme next to the nascent ureteric tips aggregates to form renal vesicles from which nephrons mature (6) . The initially simple epithelium of the distal ureter stratifies and differentiates until birth into layers of basal (B-), intermediate (I-) and superficial (S-) cells. The surrounding mesenchyme proliferates and differentiates radially into inner Lamina propria cells, medial smooth muscle cells (SMCs) and outer Tunica adventitia fibroblasts (7) .
Bmp4 is expressed in both the kidney and ureter primordia. In the latter, expression of Bmp4 is confined to the undifferentiated mesenchyme surrounding the early distal ureteric bud between E11.5 and E14.5 (Supplementary Material, Fig. S1 ) (5) . Analysis of mice heterozygous for a Bmp4 null allele initially suggested that this expression is required for ureter elongation, prevention of ectopic ureter budding and SMC formation (5, 8) . Using a conditional gene targeting approach in kidney explant cultures and application of BMP antagonists, it was later shown that Bmp4 is dose-dependently required for SMC and S-cell differentiation (9, 10) . Conditional deletion of Bmpr1a from urinary tract mesenchyme also resulted in hydroureternephrosis and reduced SMCs and S-cell investment. Surprisingly, conditional deletion of Bmp4 using the same regime was without phenotypic consequences (11) . In explant cultures, BMP4 was reported to have an anti-proliferative activity on isolated ureteric mesenchyme (12) , to promote mesenchymal cell migration (8) , and to induce SMCs and S-cells (9, 13) .
BMP4 triggers a number of downstream signaling pathways. Most prominently, phosphorylation of receptor-regulated SMAD1, SMAD5 and SMAD9 (the latter is also known as SMAD8) occurs that allows formation of hetero-oligomeric complexes with SMAD4 that bind to DNA and activate target gene transcription together with other transcription factors. BMP4 can additionally activate mitogen-activated protein kinases (MAPK) including ERK1/2, P38 and JNK, PI3 kinase/AKT, PKC and others that are involved in non-transcriptional regulation of cytoskeletal changes, migration and cell survival, or affect transcription of target genes alone or in a cooperation with the SMAD pathway (14, 15) . Bmp4-dependent phosphorylation of SMAD1/5/9 in the ureteric mesenchyme, and reduced SMC investment in embryos with conditional loss of Smad4 in this tissue suggested that the SMAD pathway mediates part of the function of Bmp4 in this tissue (10, 16) .
Here, we set out to clarify the cellular function of Bmp4 in ureter development in vivo and to characterize its effector molecules. We show that BMP4 signaling utilizes several different downstream pathways to mediate proliferation and differentiation programs in both tissue compartments of this tubular organ.
Results

Conditional inactivation of Bmp4 in the ureteric mesenchyme results in hydroureternephrosis
Embryos lacking a functional Bmp4 gene fail to form an allantois and die around E9.5 (17) . To investigate the role of Bmp4 in ureter development, we therefore employed a conditional gene inactivation approach using a Tbx18 cre line that mediates recombination in precursors of all differentiated cell types of the ureteric mesenchyme (18) , and a floxed allele of Bmp4 (Bmp4 fl ) (19 Fig. S3 ), supporting previous studies on the dose-sensitivity of Bmp4 function in the urogenital system (5, 8) . Histological analyses revealed dilatation of the renal pelvis and absence of the papilla in mutant kidneys. The ureter was strongly dilated and featured a flat and single-layered urothelium with a thin layer of surrounding mesenchyme ( Fig. 1E-H) . Markers for SMCs were severely downregulated (Tagln) or not detectable (Myh11, Tnnt2) in the mutant ureteric mesenchyme (Fig. 1I-N) . Urothelial differentiation was absent in the mutant ureter as shown by lack of KRT5, DNP63 and UPK1B expression that combinatorially marked B-cells (KRT5
. We next analysed the continuity of the ureter and the patency of its junctions by injecting ink into the renal pelvis. In the control, the ink readily passed into the bladder. In Tbx18 cre/þ ;Bmp4 fl/fl urogenital systems, the ink was retained in the ureter even when increased hydrostatic pressure was exerted ( Fig. 1U and V) . Histological analysis of the vesico-ureteric junction showed that the distal ureters ended in the urethra rather than in the dorsal bladder wall ( Fig. 1W and X). To exclude that the mesenchymal differentiation defects are simply a consequence of the increased hydrostatic pressure in the obstructed ureter, we cultured explanted ureters at E14.5, i.e. prior to urine production monitoring over 6 days for peristaltic activity. Wildtype ureters elongated extensively and initiated unidirectional peristaltic contractions, whereas Tbx18 cre/þ ;Bmp4 fl/fl ureters did not grow and never contracted ( Fig. 1Y-B' ). We conclude that loss of Bmp4 in the ureteric mesenchyme results in a complete lack of differentiated mesenchymal and epithelial cell types in the prenatal ureter. Hydroureter formation is not only caused by these functional defects but is enhanced by physical obstruction due to ectopically ending distal ureters.
Early onset of differentiation defects in Tbx18 cre/þ ;Bmp4 fl/fl ureters
To define both the onset as well as the progression of urogenital malformations in Tbx18 cre/þ ;Bmp4 fl/fl embryos, we analysed urogenital systems from E14.5 to E16.5, i.e. shortly before and after onset of urine production in the kidney (Fig. 2 for E14.5 and E16.5, Supplementary Material, Fig. S4 for E15.5). On the morphological level, Tbx18 cre/þ ;Bmp4 fl/fl urogenital systems were characterized by a more compressed appearance due to ureter shortening. At E16.5, hydroureter formation was apparent ( Fig. 2A) . Histological analysis revealed first hydronephrotic lesions (dilatation of the pelvicalyceal space) in the mutant kidney at this stage (Fig. 2B ). In the mutant ureter, the mesenchymal and epithelial compartments were hypoplastic and the epithelium was mono-layered. Cells of the inner mesenchymal ring were large and rhomboid in the control, but loosely organized, with small tangentially arranged cell bodies from E14.5 onwards in the mutant (Fig. 2C , Supplementary contract. a, adrenal; bl, bladder; hu, hydroureter; kidney; pa, papilla; pe, pelvis; t, testis; u, ureter; ue, ureteric epithelium; um, ureteric mesenchyme; ut, uterus.
Material, Fig. S4E and F) . Expression of the SM regulatory gene Myocd and the SM structural genes Myh11 and Tagln was activated at E14.5 in the proximal wildtype ureter but none of them was expressed in the mutant ureter at this and subsequent stages ( Fig Tissue hypoplasia in E14.5 Bmp4-deficient ureters suggested that Bmp4 is additionally required for survival and/or proliferation of the mesenchymal and epithelial tissue compartment prior to or at this stage. Analysis of programmed cell death by the TUNEL assay did not detect apoptotic bodies at either E12.5 or E14.5 in the mutant ureteric mesenchyme, arguing against a role for BMP4 as a survival factor (Supplementary Material, Fig. S5A and B). However, BMP4 signaling contributed substantially to the proliferation of both the inner ring of mesenchymal cells as well as of the ureteric epithelium at E12.5 and E14.5 as detected by the reduced BrdU incorporation in these domains in Bmp4-deficient ureters (Fig. 2J , Supplementary Material, Table S1A ). Hence, BMP4 is a crucial mesenchymal signal for epithelial and mesenchymal proliferation and differentiation in the early ureter.
Bmp4 is required to activate different downstream effector pathways in early ureter development
In order to identify pathways that can mediate the cellular functions of BMP4 in the developing ureter, we analysed the expression of activated, i.e. phosphorylated, components of known effectors by immunofluorescence on proximal sections of wildtype and Bmp4-deficient ureters at E12.5 and E14.5 ( Fig. 3) . In the wildtype, we detected expression of P-ERK1/2 in the ureteric epithelium at E12.5, and in the outer mesenchymal compartment at E14.5. P-AKT was found in the ureteric epithelium, and more weakly in the surrounding mesenchyme at E12.5 and E14.5. Expression of P-SMAD1/5/9 was found in the ureteric mesenchyme at both stages. Weak expression was detected in the ureteric epithelium at E14.5. P-P38 was expressed in the ureteric mesenchyme at both stages, as well as in some epithelial cells. P-JNK expression was not detected at these stages but in adult kidneys used as a staining control (Supplementary Material, Fig. S6 ). In Bmp4-deficient ureters expression of these components was dramatically reduced at both stages ( Different Bmp4-dependent pathways act pro-proliferative
To analyse which of the kinase effectors contributes to the proproliferative function of BMP4 signaling in the ureter, we specifically inhibited P38 with SB203580 (20) , ERK1/2 with PD98059 (21), and AKT with MK2206 (22) in ureter explant cultures and determined the BrdU labeling index after 24 h. In E12.5 explants, epithelial proliferation was strongly reduced by individual treatment with all three inhibitors; mesenchymal proliferation was inhibited by AKT inhibitor only (Fig. 4A , Supplementary Material, Table S1B ). In E14.5 ureter explants, treatment with the AKT inhibitor affected proliferation in the epithelium and in both domains of the mesenchyme (Fig. 4B , Supplementary Material, Table S1B ). The role of the SMAD pathway in this cellular program was determined in explants of ureters with conditional (Tbx18 cre -mediated) inactivation of the Smad4 gene in the mesenchymal compartment (23) . In Tbx18 cre/þ ;Smad4 fl/fl ureter explants proliferation was unaffected at both E12.5 and E14.5 ( Fig. 4C and D, Supplementary Material, Table S1C ). Smad4-deficient ureters treated with the P38 inhibitor SB203580 showed reduced proliferation in the inner mesenchymal compartment at E12.5 which was further lowered by additional administration of the AKT inhibitor MK2206 (Fig. 4C , Supplementary Material, Table S1C ). In none of the treated cultures did we observe an induction of apoptosis (Supplementary Material, Fig. S5C-F ). This analysis, together with the localization study, identifies AKT as the most potent pro-proliferative effector both in the epithelium as well as in the mesenchyme of ;Bmp4 fl/fl embryos at E12.5 and E14.5 for expression of activated components of canonical and non-canonical downstream pathways of BMP4. In the epithelial compartment, expression of P-ERK1/2, P-AKT, P-P38 and P-SMAD1/5/9 depends on Bmp4; in the ureteric mesenchyme P-Smad1/5/9, P-AKT and P-P38 expression requires Bmp4. Genotypes, stages and probes are as indicated.
the early developing ureter. ERK1/2 (and weakly P38) provide an additional minor input for epithelial proliferation at E12.5, whereas SMAD and P38 do so in the mesenchymal compartment at this stage.
SMAD, P-38 and AKT pathways cooperate downstream of Bmp4 in SMC differentiation of the ureteric mesenchyme
A recent study showed that conditional deletion of Smad4 in the ureteric mesenchyme results in ureteropelvic junction obstruction (UPJO) and associated hydronephrosis around birth. SMCs were reported to be present in the mutant ureter but reduced in number indicating that additional SMAD4-independent pathways are required for SMC differentiation downstream of BMP4 (16 Fig. S10D-G) . We conclude that SMAD4 signaling is required in Table S1 , B and C. the ureteric mesenchyme for proper temporal activation and full expression of the SMC program. To explore whether P38 and AKT kinase pathways are combinatorially required with Smad4 in SMC differentiation, we performed pharmacological inhibition experiments in ureter explants of E12.5 wildtype and Tbx18 cre/þ ;Smad4 fl/fl embryos (Fig. 5) . In wildtype controls, the SM structural proteins ACTA2 and TAGLN were strongly expressed in the inner mesenchymal compartment of the ureter after 6 days of culture ( Fig. 5A and E) . Inhibition of P38 by SB203580 affected the number of ACTA2 þ TAGLN þ cells and the level of their expression slightly ( Fig. 5B and F) . Treatment with the AKT inhibitor MK2206 reduced the overall cell number but the relative number of cells strongly expressing ACTA2 and TAGLN appeared weakly affected ( Fig. 5C and G) . In contrast, combinatorial inhibition of P38 and AKT strongly diminished the number of ACTA2 þ TAGLN þ SMCs (Fig. 5D and H) . Tbx18 cre/þ ;Smad4 fl/fl ureters presented with a reduced number of SMCs ( Fig. 5I and M) . Application of SB203580 or MK2206 to Tbx18 cre/þ ;Smad4 fl/fl ureters reduced the number of TAGLN and ACTA2 expressing cells further but affected the levels of the two structural proteins only mildly (Fig. 5J, N, K, O) . Finally, loss of Smad4 in the presence of P38 and AKT inhibitors reduced cell number and almost completely abolished expression of the two SMC marker proteins ( Fig. 5L and P) . We conclude that the SMAD4, P38 and AKT effector pathways act combinatorially downstream of BMP4 to mediate SMC differentiation in the ureteric mesenchyme.
AKT is the major effector of urothelial differentiation
We next addressed the individual and combined contribution of the effector pathways to epithelial differentiation by pharmacological inhibition in ureter explant cultures (Fig. 6 ). We used immunofluorescence of DNP63 expression after 6 days of culture as a readout since this marker indicates onset of epithelial differentiation at E14.5 in vivo (7). Treatment with the AKT inhibitor MK2206 and the ERK1/2 inhibitor PD98059 led to a strong and weak reduction of DNP63 expression, respectively, while the P38 inhibitor SB203580 left DNP63 expression levels unaltered ( Fig. 6A-D) . Combined administration of P38 inhibitor or ERK1/2 inhibitor with AKT inhibitor enhanced the effect slightly compared to AKT inhibitor alone ( Fig. 6E and F) . Western blot analysis for DNP63 expression on cultured pools of 10 ureters for each condition confirmed these findings ( Fig. 6G and H) . Since our pharmacological inhibition experiments identified AKT as the major effector for proliferation and epithelial differentiation, we wished to further validate the significance of this kinase by a rescue experiment. For this, we abolished BMP4 function in ureter explant cultures by administration of NOGGIN which sequesters BMP4 from its receptor (24) . Importantly, administration of NOGGIN recapitulated the Bmp4 loss-of-function phenotype. The tissue was severely hypoplastic and SMC and I-cell markers were not expressed (Fig. 6I-L) . Addition of the AKT activator SC-79 (25) to NOGGIN-treated ureters rescued tissue hypoplasia and expression of DNP63; ACTA2 expression was not restored ( Fig. 6M and N) . This argues that AKT is sufficient to trigger proliferation in both tissue compartments, and to induce the epithelial but not the mesenchymal differentiation program.
Discussion
BMP4 signaling promotes coordinated proliferation and differentiation of mesenchymal and epithelial progenitors in the ureter
Previous analysis of mice either heterozygous for a null allele of Bmp4 or with a conditional deletion of Bmpr1a, and of ureter explants with antagonized BMP4 function, indicated that reduced doses of BMP4 are associated with reduced expression of SMC and S-cell markers (5, (8) (9) (10) (11) . While this suggested an important role for Bmp4 in mesenchymal and epithelial differentiation, it left open the extent to which BMP4 is essential to initiate and/or maintain these programs. Our analysis of newborn mice with conditional loss of all Bmp4 function in the ureteric mesenchyme not only revealed a complete loss of expression of SM structural proteins and of the SM regulatory protein MYOCD but also of markers for all three urothelial lineages, i.e. of I-, B-and S-cells in newborns. Inspection at earlier embryonic stages showed that the SMC differentiation program was not activated in the mesenchyme, and that stratification and differentiation of the epithelium did not occur. Together, this argues for a larger role for BMP4 than previously anticipated, namely as the decisive signal for cell differentiation in both tissue compartments of the ureter.
Analysis of Bmp4-heterozygous mice revealed tissue hypoplasia and reduced length of ureters, but the underlying cellular changes were not addressed in vivo (5). Moreover, gain-offunction experiments based on administration of BMP4 protein to tissue explant cultures provided somewhat conflicting data with respect to the role of BMP4 in the expansion and/or maintenance of the mesenchymal progenitor pool (8, 12, 26) . We deem that these differences reflect changes in the experimental setting, including variable tissue types, BMP4 concentrations or assay systems. The epithelial compartment was not the target of these functional assays. Our analysis did not detect apoptosis associated with the complete loss of Bmp4 in the ureteric mesenchyme nor did we see changes in cell migration. However, we found strongly reduced cell proliferation rates both in the mesenchymal and epithelial compartments at E12.5 and E14.5, showing that Bmp4 is required for expansion of the two progenitor pools. This defines BMP4 as the crucial signal that couples the cellular programs of the mesenchymal and epithelial tissue compartments during early ureter development. This tissue interconnectivity is of utmost relevance as it ensures the homogenous growth of the early ureter as well as the coordinate acquisition of mature cell types that enable the efficient removal of the urine from the renal pelvis from E16.5 onwards.
Bmp4 expression in the ureteric mesenchyme has been shown to depend on epithelial SHH. Loss of Shh is also associated with epithelial defects and reduced SMC investment, arguing that BMP4 relays the activity of the epithelial SHH signal in the mesenchyme and transmits it back to the epithelium (10) (11) (12) .
We like to stress that the loss of Bmp4 in the ureteric mesenchymal cell lineage did not result in a failure to establish a ureter or in ectopic branches from the ureter, arguing against a role of this gene in ureter specification and in prevention of ureteric branching. However, we did observe physical obstruction of the distal ureter associated with altered bladder insertion. This strongly supports an earlier notion that BMP4 regulates the positioning of the ureteric bud in the early metanephric field (5). The combined requirements of Bmp4 for ureter budding, ureter elongation and differentiation translate into hydroureter formation and associated hydronephrosis as a consequence of physical and complete functional obstruction in Tbx18 cre/þ ;Bmp4 fl/fl mice. Given that the heterozygous loss of Bmp4 also resulted in hydroureternephrosis, albeit at a reduced frequency, this easily explains why humans born with one functional copy of BMP4 are likely to suffer from a similar congenital defect that may even be enhanced due to additional requirements of Bmp4 in kidney and bladder development (5).
BMP4 uses different effector pathways for control of epithelial and mesenchymal proliferation and differentiation
Previous work showed that mice with a conditional knockout of Smad4 in the ureteric mesenchyme develop UPJO at birth and exhibit lower cell density in the SMC layer at birth. Interestingly, morphological but not differentiation changes were also observed in the ureteric epithelium (16) . Together with the observation that SMAD1/5/9 phosphorylation is reduced upon lowering BMP4 levels, this suggested that SMAD1/5/ 9-SMAD4 complexes transmit only a minor part of the activity of BMP4 in SMC differentiation (10, 11) . The Tbx18 cre/þ ;Smad fl/fl urogenital systems analysed in this study were characterized by weak bilateral hydroureter with associated hydronephrosis with more pronounced proximal dilatation similar to UPJO in approximately 20% of the cases. However, we did not observe physical obstruction nor did we find epithelial changes. This discrepancy to the earlier study may result from the different genetic background of the mice, or the different Cre lines used for recombination. We employed a cre knock-in line of the Tbx18 locus that faithfully mimics the endogenous expression whereas Tripathi and colleagues used a BAC transgene which may confer ectopic cre expression (16, 27, 28) . Importantly, we also found reduced SMC density at newborn stages, selective reduction of some SM structural genes and newly discovered a delay in the onset of SMC differentiation, confirming that SMAD signaling mediates some aspect of BMP4 function in SMC differentiation. We also analysed proliferation and apoptosis in our mutants, and did not find changes, proving that the proproliferative function of BMP4 in the mesenchymal and epithelial compartments is not exclusively regulated by SMAD signaling.
In fact, we found that phosphorylation, i.e. activation of ERK1/2, AKT and P-38 kinases in the epithelium, and of AKT and P-38 in the mesenchyme of the early ureter also depends on mesenchymal Bmp4. Pharmacological inhibition and rescue experiments uncovered AKT as the major mediator of proliferation and differentiation in the ureteric epithelium. Additional minor input in the epithelium may derive from P-38 and ERK1/2.
Previous work provided a paradigm for BMP-dependency of epithelial DNP63 expression in Xenopus and in zebrafish, and in Mü llerian duct differentiation, where it acts in concert with Activin and FGF7 (29) (30) (31) . Interestingly, a direct activation of DNP63 expression by SMADs was suggested in these studies. We have not addressed a specific (genetic) requirement for SMAD signaling in epithelial development of the ureter. Although levels of P-SMAD1/5/9 appear low in wildtype ureteric epithelium at E14.5, inhibition of AKT, ERK1/2 and P38 does not completely repress DNP63 expression, making an additional SMAD input conceivable.
In the mesenchymal compartment of the ureter, proliferation also critically depended on AKT activity, whereas complete loss of SMC differentiation resulted from the combined inhibition of SMAD, AKT and P38. Our finding that individual inhibition of AKT, P38 and ERK1/2 did not result in SMC reduction is in line with a previous pharmacological inhibition experiment (32) . In sum, our experiments suggest that BMP4 function in proliferation and differentiation of the two tissue compartments of the ureter is combinatorially mediated by several different effectors as in other systems (33) (34) (35) . AKT is the most relevant factor for proliferation and epithelial differentiation (Fig. 6O ).
Materials and Methods
Animals
All mouse lines used in this study were maintained on an NMRI outbred background. In the Bmp4 allele used (Bmp4 tm3Blh , synonym: Bmp4 fl ) Cre recombinase recognition sites (loxP) were placed upstream and downstream of exons 3 and 4, within intron 2 and 3' of the poly-adenylation site, such that Cre recombination excises the entire Bmp4 protein coding sequence (19) . In the Smad4 allele used (Smad4 tm1Rob , synonym: Smad4 fl ) the first codon was flanked with loxP sites (23) . Recombination of these floxed alleles in the ureteric mesenchyme was achieved with the Tbx18 tm4(cre)Akis line (synonym: Tbx18 cre ) line previously generated in the lab (18) . Additional sites of recombination in the urogenital system include the coelomic epithelium from which the adrenogonadal primordium develops, aspects of the bladder mesenchyme and the renal stroma (27, 36 females. For timed pregnancies, vaginal plugs were checked in the morning after mating, and noon was defined as embryonic day (E) 0.5. Embryos and urogenital systems were dissected in PBS. Ureters for explant cultures were dissected in L-15 Leibovitz medium (Biochrom). Specimens were fixed in 4% PFA/ PBS, transferred to methanol and stored at -20 C prior to immunofluorescence or in situ hybridization analyses. PCR genotyping was performed on genomic DNA prepared from yolk sac or tail biopsies. All animal work conducted for this study was performed according to European and German legislation.
Organ cultures
Ureters were dissected from the embryo, explanted on 0.4 mm polyester membrane Transwell supports (Corning) and cultured at the air-liquid interface with DMEM/F12 (Gibco) supplemented with 10% FCS (Biochrom), 1x Penicillin/Streptomycin (Gibco), 1x
Pyruvate (Gibco) and 1x Glutamax (Gibco). Pathway inhibitors were purchased from MedChemExpress and dissolved in DMSO as follows: P38 MAPK catalytic activity inhibitor SB203580 (HY-10256, 10 mM), ERK1/2 activation inhibitor PD98059 (HY-12028, 50 mM), AKT activation inhibitor MK2206 (HY-10358, 500 nM). BMP4 inhibitor NOGGIN purchased from antikoerper-online.de (ABIN2018288, 10 mg/ml) was dissolved in water, and AKT activator SC-79 purchased from Sigma-Aldrich (SML0749, 5 mM) was dissolved in DMSO. Inhibitor concentrations were based on previous reports in cell or organ culture systems and adjusted to avoid toxicity (10, (37) (38) (39) (40) . Culture medium containing inhibitor or DMSO was replaced every second day.
Ink injection
Ink injection experiments to visualize the ureteropelvic lumen were performed as previously described (18) .
Histological analysis
Embryos and urogenital systems were paraffin-embedded and kidneys and ureters sectioned to 5 mm. Hematoxylin and eosin staining was performed according to standard procedures.
In situ hybridization analysis
Non-radioactive in situ hybridization analysis of gene expression was performed on whole ureters or on 10-mm paraffin sections of the proximal region with digoxigenin-labeled antisense riboprobes as described (41, 42) . At least three embryos of each genotype were used for each analysis.
Immunofluorescent detection of antigens
Immunofluorescence staining was performed on 5-mm paraffin sections using monoclonal rabbit-anti-P-SMAD1/5/9 (1:500, #13280, Cell Signaling), monoclonal rabbit-anti-P-P38 MAPK (1:500, #4631, Cell Signaling), monoclonal rabbit-anti-P-AKT (1:500, #9271, Cell Signaling), monoclonal rabbit-anti-P-ERK1/2 (1:500, #9102, Cell Signaling), monoclonal mouse-anti-P-JNK (1:100, Santa Cruz Biotechnology), polyclonal rabbit-anti-TAGLN (1:250, ab14106, Abcam), monoclonal mouse-anti-ACTA2 (1:250, A5228, SigmaAldrich), polyclonal rabbit-anti-DNP63 (1:250, #619001, Biolegend), polyclonal rabbit-anti-KRT5 (1:250, #PRB-160P, Covance), monoclonal mouse-anti-UPK1B (1:250, WH0007348M2, Sigma-Aldrich), and monoclonal mouse-anti-BrdU (1:250, 1170376, Roche). Biotinylated goat-anti-rabbit IgG (1:250, 111065033, Dianova), biotinylated goatanti-mouse IgG (1:250, Jackson ImmunoResearch), Alexa488-conjugated goat-anti-rabbit IgG (1:500, A11034, Molecular Probes) and Alexa555-conjugated goat-anti-mouse IgG (1:500, A21422, Molecular Probes) were used as secondary antibodies. The signals of P-specific, DNP63 and BrdU primary antibodies were amplified using the Tyramide Signal Amplification (TSA) system (NEL702001KT, Perkin Elmer). Before staining, paraffin sections were deparaffinized and cooked for 15-20 min in antigen unmasking solution (H-3300, Vector Laboratories). Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI). At least three embryos of each genotype were used for each analysis.
Cell proliferation and apoptosis assays
In vivo cell proliferation rates were investigated by the detection of incorporated BrdU on 5-mm paraffin sections (43) . In explant cultures, ureters were incubated with BrdU at a final concentration of 3.3 mg/ml for 3 h. For each specimen (n ¼ 5) 12 sections of the proximal ureter were analysed. The BrdU-labeling index was defined as the number of BrdU-positive nuclei relative to the total number of nuclei as detected by DAPI counterstaining in histologically defined compartments of the ureter. Apoptosis in tissues was assessed by the TUNEL assay using the ApopTag Plus Fluorescein In Situ Apoptosis Detection Kit (Chemicon) on 5-lm paraffin sections. Statistical analysis was performed using the two-tailed Student's t-test. Data were expressed as mean 6 standard deviation. For relative analyses wildtype values were set to 1. Differences were considered significant with a P-value below 0.05 (*P < 0.05), highly significant (**P 0.005) and extremely significant (***P 0.0005).
Western blotting
Protein lysates were prepared from ureter explant cultures (10 per condition) using NP40 buffer. 7 lg of total protein were subjected to SDS-PAGE analysis followed by immunoblotting according to standard protocols. Primary antibodies: polyclonal rabbit-anti-DNP63 (1:500, 619001, Biolegend) and monoclonal mouse-anti-Actin C4 (1:1000, 69100, MP Biomedicals) in TBS containing 0.1% Tween-20 and 5% Milk.
Image analysis
Sections were photographed using a Leica DM5000 microscope with Leica DFC300FX digital camera or a Leica DM6000 microscope with Leica DFC350FX digital camera and afterwards processed in Adobe Photoshop CS4. Immunoblot signals were quantified by densitometry using Image J software (1.47v) (44) .
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